TXA (TRANEXAMIC ACID)
Global Regulation Summary
Overview of current status across major international markets.
Detailed Regional Status
| Region | Status | Max Conc. | Conditions | Source |
|---|---|---|---|---|
| πͺπΊ EU | Unknown | - | - | Official β |
| πΊπΈ USA | Unknown | - | - | Official β |
| π―π΅ Japan | Unknown | - | - | Official β |
| π°π· Korea | Unknown | - | - | Official β |
| π¬π§ UK | Unknown | - | - | Official β |
πΏ Natural Sources
Tranexamic acid is entirely synthetic and does not occur naturally. It is a synthetic derivative of the amino acid lysine, chemically modified for pharmaceutical and cosmetic applications.
π How It's Made
First synthesized in 1962 by Japanese researchers Shosuke and Utako Okamoto. Developed from studies on 1-(aminomethyl)-cyclohexane-4-carboxylic acid (AMCHA), found to be 27 times more powerful than previous compounds. Published in Keio Journal of Medicine in 1962. Modern synthesis produces pharmaceutical-grade material for both topical and systemic use.
π Uses in Cosmetics
Used at 2-5% for treating melasma and hyperpigmentation. Inhibits UV-induced melanin synthesis by blocking plasminogen-to-plasmin conversion in keratinocytes, reducing inflammatory mediators (arachidonic acid, prostaglandins). 3-5% concentrations for severe pigmentation. Water-soluble, stable in mid-range pH. Found in serums, creams, ampoules, often combined with niacinamide or kojic acid.
π¬ Other Applications
FDA-approved for heavy menstrual bleeding and hemophilia-related bleeding prevention. Used in surgery to reduce intraoperative blood loss (cesarean, cardiac, orthopedic). Trauma treatment (CRASH-2 trial). Postpartum hemorrhage (WOMAN trial). Dental procedures for anticoagulated patients. WHO List of Essential Medicines. May be administered orally, topically, or intravenously.
π‘ Fun Facts
- β’ Discovered in 1962 by Dr. Utako Okamoto while searching for a drug to treat post-partum hemorrhage - she found it 27 times more powerful than previous compounds
- β’ Serendipitously discovered for melasma treatment in 1979 when a patient being treated for another condition experienced unexpected skin brightening
- β’ 3% topical TXA shows efficacy comparable to hydroquinone plus dexamethasone for melasma, but with superior safety profile
Frequently Asked Questions
What is TRANEXAMIC ACID used for in cosmetics?
TRANEXAMIC ACID is primarily used for skin conditioning in cosmetic products. It also serves as skin brightening, anti-inflammatory. The ingredient is commonly found in moisturizers, lotions, and creams.
Which countries regulate TRANEXAMIC ACID?
TRANEXAMIC ACID is approved for cosmetic use in all major markets: , with no significant restrictions.
Where can I find official regulation information about TRANEXAMIC ACID?
Official information about TRANEXAMIC ACID regulations can be found on government websites: EU CosIng database, US FDA Cosmetics page, Japan MHLW cosmetics standards, UK Government cosmetics guidance, and Korea MFDS. Always verify regulatory status with these official sources before making formulation decisions.
Disclaimer
The information on this website is for educational and informational purposes only and is not intended as medical advice. While we strive for accuracy based on official government databases, cosmetic regulations change frequently. Always consult with a qualified professional or refer to the latest official regulatory documents for compliance. We are not responsible for any actions taken based on the information provided here.